vancomycin has been researched along with Allergic Encephalomyelitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchimano, P; Britton, GJ; Clemente, JC; Cox, LM; Faith, JJ; Iwanowski, K; Liu, S; Smith, EM; Tankou, SK; Wallach, DS; Weiner, HL | 1 |
| Casavant, EP; Cox, LM; Elias, JE; Gonzalez, CG; Tankou, SK; Weiner, HL | 1 |
| Akkermans, LM; Cobelens, PM; Fleer, A; Harmsen, W; Heijnen, CJ; Kavelaars, A; Nieuwenhuis, EE; Verhoef, J; Visser, MR | 1 |
3 other study(ies) available for vancomycin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyrates; Clostridiales; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Gastrointestinal Microbiome; Humans; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuroinflammatory Diseases; Nuclear Receptor Subfamily 1, Group F, Member 3; Vancomycin | 2022 |
Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Feces; Female; Gastrointestinal Microbiome; Gene Expression Regulation; Mice; Multiple Sclerosis; Protease Inhibitors; Proteomics; Vancomycin | 2019 |
Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Corticosterone; Encephalomyelitis, Autoimmune, Experimental; Escherichia coli; Ileum; Intestines; Male; Rats; Rats, Inbred Lew; Severity of Illness Index; T-Lymphocytes; Vancomycin | 2000 |